NantHealth Stock Price, News & Analysis (NASDAQ:NH)

$3.29 +0.10 (+3.13 %)
(As of 02/19/2018 04:00 PM ET)
Previous Close$3.29
Today's Range$3.17 - $3.34
52-Week Range$2.60 - $7.96
Volume79,972 shs
Average Volume152,421 shs
Market Capitalization$356.40 million
P/E Ratio-1.85
Dividend YieldN/A
Beta0.21

About NantHealth (NASDAQ:NH)

NantHealth logoNantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient's tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NH
CUSIPN/A
Phone310-883-1300

Debt

Debt-to-Equity Ratio0.93%
Current Ratio2.38%
Quick Ratio2.36%

Price-To-Earnings

Trailing P/E Ratio-1.84831460674157
Forward P/E Ratio-2.44
P/E GrowthN/A

Sales & Book Value

Annual Sales$100.38 million
Price / Sales3.55
Cash FlowN/A
Price / CashN/A
Book Value$3.39 per share
Price / Book0.97

Profitability

Trailing EPS($1.78)
Net Income$-184,100,000.00
Net Margins-225.76%
Return on Equity-46.09%
Return on Assets-25.23%

Miscellaneous

EmployeesN/A
Outstanding Shares108,330,000

NantHealth (NASDAQ:NH) Frequently Asked Questions

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth Inc (NASDAQ:NH) issued its earnings results on Thursday, November, 9th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.01. The company earned $21.76 million during the quarter, compared to analyst estimates of $29.42 million. NantHealth had a negative return on equity of 46.09% and a negative net margin of 225.76%. The business's revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.18) EPS. View NantHealth's Earnings History.

Where is NantHealth's stock going? Where will NantHealth's stock price be in 2018?

4 brokerages have issued 12-month price objectives for NantHealth's stock. Their forecasts range from $5.00 to $13.00. On average, they expect NantHealth's share price to reach $9.00 in the next year. View Analyst Ratings for NantHealth.

What are Wall Street analysts saying about NantHealth stock?

Here are some recent quotes from research analysts about NantHealth stock:

  • 1. According to Zacks Investment Research, "Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets of molecular, clinical, operational and financial data points derived from novel and traditional sources. Nant Health, LLC is based in CULVER CITY, United States. " (1/11/2018)
  • 2. Cantor Fitzgerald analysts commented, "NantHealth shares are trading lower by about 18% today. The weakness is probably related to a negative article published at StatNews.com. The article claims that Dr. Patrick Soon-Shiong, Nanthealth's CEO, donated $12 million to the University of Utah. In return for the contribution, the article suggests that the University was committed to spend $10 million in "Omics Analysis". As noted above, the company disclosed on its 3Q16 conference call that the company did not recognize revenue related to 180 sequences ordered by the University of Utah. The article also tries to indicate that the company overstated the number of GPS Cancer tests it reported. It claims the orders from the University of Utah were for sequences, not for GPS Cancer tests. While the tests completed were used for preclinical research, the GPS Cancer test is a sequence by definition. Accordingly, we have no problem with the company classifying the Utah orders as GPS Cancer tests given the disclosure and the fact that it did not recognize revenue from the tests." (3/6/2017)

Who are some of NantHealth's key competitors?

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:

  • Patrick Soon-Shiong M.D., Chairman of the Board, Chief Executive Officer, Founder (Age 64)
  • Paul A. Holt, Chief Financial Officer (Age 50)
  • Michael D. Blaszyk, Independent Director (Age 64)
  • Mark Burnett, Independent Director (Age 56)
  • Kirk K. Calhoun, Independent Director (Age 73)
  • Michael S. Sitrick, Independent Director (Age 69)

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Who owns NantHealth stock?

NantHealth's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.11%), Advisor Group Inc. (0.14%), Millennium Management LLC (0.10%), Goldman Sachs Group Inc. (0.09%), SG Americas Securities LLC (0.07%) and Deutsche Bank AG (0.04%). Company insiders that own NantHealth stock include Healthcare Solution Allscripts, Patrick Soon-Shiong and Ronald Allen Louks. View Institutional Ownership Trends for NantHealth.

Who sold NantHealth stock? Who is selling NantHealth stock?

NantHealth's stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc. and Goldman Sachs Group Inc.. View Insider Buying and Selling for NantHealth.

Who bought NantHealth stock? Who is buying NantHealth stock?

NantHealth's stock was acquired by a variety of institutional investors in the last quarter, including Advisor Group Inc., Millennium Management LLC, SG Americas Securities LLC, Citadel Advisors LLC and Deutsche Bank AG. Company insiders that have bought NantHealth stock in the last two years include Healthcare Solution Allscripts and Patrick Soon-Shiong. View Insider Buying and Selling for NantHealth.

How do I buy NantHealth stock?

Shares of NantHealth can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NantHealth stock can currently be purchased for approximately $3.29.

How big of a company is NantHealth?

NantHealth has a market capitalization of $356.40 million and generates $100.38 million in revenue each year. The company earns $-184,100,000.00 in net income (profit) each year or ($1.78) on an earnings per share basis.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]


MarketBeat Community Rating for NantHealth (NH)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  143 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  257
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NantHealth (NASDAQ:NH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.00$9.00$9.00$9.25
Price Target Upside: 152.81% upside152.81% upside152.81% upside215.70% upside

NantHealth (NASDAQ:NH) Consensus Price Target History

Price Target History for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ:NH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/17/2017Canaccord GenuityLower Price TargetBuy -> Buy$6.00 -> $5.00N/AView Rating Details
9/28/2017Jefferies GroupReiterated RatingBuy$5.00LowView Rating Details
4/3/2017Cantor FitzgeraldLower Price TargetOverweight$15.00 -> $13.00HighView Rating Details
4/1/2017FBR & CoSet Price TargetBuy$13.00HighView Rating Details
6/27/2016First AnalysisInitiated CoverageOverweight$18.00N/AView Rating Details
6/27/2016CowenInitiated CoverageOutperform$19.00N/AView Rating Details
(Data available from 2/19/2016 forward)

Earnings

NantHealth (NASDAQ:NH) Earnings History and Estimates Chart

Earnings by Quarter for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ NH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.14)($0.13)$29.42 million$21.76 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.26)($0.58)$31.28 million$26.23 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.20)($0.24)$29.06 million$22.51 millionViewN/AView Earnings Details
3/30/2017Q4 2016($0.19)($0.18)$30.02 million$24.10 millionViewN/AView Earnings Details
11/7/2016Q3 2016($0.27)($0.22)ViewN/AView Earnings Details
8/9/2016Q2 2016($0.65)($0.59)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

NantHealth (NASDAQ:NH) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.35 EPS
Next Year EPS Consensus Estimate: $-0.74 EPS

Dividends

Dividend History for NantHealth (NASDAQ:NH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

NantHealth (NASDAQ NH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 58.00%
Institutional Ownership Percentage: 6.63%
Insider Trades by Quarter for NantHealth (NASDAQ:NH)
Insider Trades by Quarter for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ NH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/6/2018Ronald Allen LouksCOOSell6,475$3.02$19,554.5089,690View SEC Filing  
1/8/2018Ronald Allen LouksCOOSell6,175$3.52$21,736.0089,690View SEC Filing  
12/6/2017Ronald Allen LouksCOOSell5,245$3.03$15,892.3589,690View SEC Filing  
11/6/2017Ronald Allen LouksCOOSell6,705$3.39$22,729.9510,000View SEC Filing  
10/6/2017Ronald Allen LouksCOOSell26,820$4.28$114,789.60View SEC Filing  
6/7/2016Healthcare Solution AllscriptsMajor ShareholderBuy714,286$14.00$10,000,004.0015,000,000View SEC Filing  
6/7/2016Patrick Soon-ShiongCEOBuy357,143$14.00$5,000,002.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

NantHealth (NASDAQ NH) News Headlines

Source:
DateHeadline
[$$] Former Officials Raise Questions About New LA Times Owner’s Business[$$] Former Officials Raise Questions About New LA Times Owner’s Business
finance.yahoo.com - February 12 at 8:56 AM
[$$] Former Officials Raise Questions About New LA Times Owners Business[$$] Former Officials Raise Questions About New LA Times Owner's Business
finance.yahoo.com - February 10 at 8:54 AM
Baltimore Sun parent Tronc to sell Los Angeles Times to L.A. billionaireBaltimore Sun parent Tronc to sell Los Angeles Times to L.A. billionaire
www.bizjournals.com - February 8 at 9:05 AM
Insider Selling: NantHealth Inc (NH) COO Sells 6,475 Shares of StockInsider Selling: NantHealth Inc (NH) COO Sells 6,475 Shares of Stock
www.americanbankingnews.com - February 8 at 4:20 AM
Tronc to sell Los Angeles Times: sourceTronc to sell Los Angeles Times: source
www.reuters.com - February 7 at 9:02 AM
Tronc to sell Los Angeles Times to L.A.’s richest personTronc to sell Los Angeles Times to L.A.’s richest person
www.bizjournals.com - February 7 at 9:02 AM
Tronc to sell the Los Angeles Times to billionaire biotech investor Patrick Soon-ShiongTronc to sell the Los Angeles Times to billionaire biotech investor Patrick Soon-Shiong
finance.yahoo.com - February 7 at 9:02 AM
Omnicell (OMCL) & NantHealth (NH) Financial AnalysisOmnicell (OMCL) & NantHealth (NH) Financial Analysis
www.americanbankingnews.com - February 6 at 5:10 AM
NantHealth Inc (NH) Given Average Recommendation of "Buy" by BrokeragesNantHealth Inc (NH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 5 at 1:28 AM
Head to Head Review: Press Ganey (PGND) vs. NantHealth (NH)Head to Head Review: Press Ganey (PGND) vs. NantHealth (NH)
www.americanbankingnews.com - February 3 at 11:04 AM
NantHealth (NH) Downgraded by BidaskClubNantHealth (NH) Downgraded by BidaskClub
www.americanbankingnews.com - January 27 at 6:40 AM
NantHealth: A Promising Individualized Medicine Company - Seeking AlphaNantHealth: A Promising Individualized Medicine Company - Seeking Alpha
seekingalpha.com - January 23 at 8:32 AM
NantHealth Inc (NH) Receives Consensus Rating of "Buy" from AnalystsNantHealth Inc (NH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - January 11 at 1:10 AM
Ronald Allen Louks Sells 6,175 Shares of NantHealth Inc (NH) StockRonald Allen Louks Sells 6,175 Shares of NantHealth Inc (NH) Stock
www.americanbankingnews.com - January 9 at 7:56 PM
Contrasting Veeva Systems (VEEV) and NantHealth (NH)Contrasting Veeva Systems (VEEV) and NantHealth (NH)
www.americanbankingnews.com - January 9 at 7:32 AM
Greenway Health (GWAY) versus NantHealth (NH) Critical ComparisonGreenway Health (GWAY) versus NantHealth (NH) Critical Comparison
www.americanbankingnews.com - December 28 at 7:34 PM
Analyzing Veeva Systems (VEEV) and NantHealth (NH)Analyzing Veeva Systems (VEEV) and NantHealth (NH)
www.americanbankingnews.com - December 28 at 1:13 PM
NantHealth (NH) Stock Rating Lowered by Zacks Investment ResearchNantHealth (NH) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - December 23 at 11:24 PM
NantHealth (NH) Upgraded to "Buy" by Zacks Investment ResearchNantHealth (NH) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - December 23 at 6:22 PM
Calculating The Intrinsic Value Of NantHealth Inc (NASDAQ:NH)Calculating The Intrinsic Value Of NantHealth Inc (NASDAQ:NH)
finance.yahoo.com - December 19 at 8:35 AM
NantHealth (NH) & The Competition Head-To-Head AnalysisNantHealth (NH) & The Competition Head-To-Head Analysis
www.americanbankingnews.com - December 18 at 11:10 PM
Critical Comparison: NantHealth (NH) versus The CompetitionCritical Comparison: NantHealth (NH) versus The Competition
www.americanbankingnews.com - December 18 at 1:46 PM
Reviewing NantHealth (NH) and The CompetitionReviewing NantHealth (NH) and The Competition
www.americanbankingnews.com - December 17 at 11:36 PM
NantHealth Inc (NH) Given Consensus Recommendation of "Buy" by BrokeragesNantHealth Inc (NH) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - December 17 at 1:50 AM
NantHealth (NH) versus Fluidigm (FLDM) Critical ComparisonNantHealth (NH) versus Fluidigm (FLDM) Critical Comparison
www.americanbankingnews.com - December 15 at 11:16 PM
NantHealth (NH) & Its Competitors Head to Head ReviewNantHealth (NH) & Its Competitors Head to Head Review
www.americanbankingnews.com - December 15 at 7:10 PM
Analyzing NantHealth (NH) & athenahealth (ATHN)Analyzing NantHealth (NH) & athenahealth (ATHN)
www.americanbankingnews.com - December 15 at 9:52 AM
NantHealth (NH) vs. Its Competitors Head-To-Head AnalysisNantHealth (NH) vs. Its Competitors Head-To-Head Analysis
www.americanbankingnews.com - December 15 at 3:10 AM
NantHealth (NH) and Its Competitors Critical ComparisonNantHealth (NH) and Its Competitors Critical Comparison
www.americanbankingnews.com - December 14 at 9:50 AM
Reviewing NantHealth (NH) & Evolent Health (EVH)Reviewing NantHealth (NH) & Evolent Health (EVH)
www.americanbankingnews.com - December 13 at 7:26 PM
Contrasting NantHealth (NH) and Its RivalsContrasting NantHealth (NH) and Its Rivals
www.americanbankingnews.com - December 12 at 9:34 PM
Financial Contrast: NantHealth (NH) and The CompetitionFinancial Contrast: NantHealth (NH) and The Competition
www.americanbankingnews.com - December 12 at 11:08 AM
Contrasting NantHealth (NH) & Its RivalsContrasting NantHealth (NH) & Its Rivals
www.americanbankingnews.com - December 11 at 7:16 PM
NantHealth (NH) Downgraded by BidaskClub to Strong SellNantHealth (NH) Downgraded by BidaskClub to Strong Sell
www.americanbankingnews.com - December 10 at 1:42 PM
Analyzing NantHealth (NH) and Its RivalsAnalyzing NantHealth (NH) and Its Rivals
www.americanbankingnews.com - December 10 at 12:14 PM
Comparing NantHealth (NH) and Its RivalsComparing NantHealth (NH) and Its Rivals
www.americanbankingnews.com - December 10 at 5:22 AM
Comparing NantHealth (NH) and Healthequity (HQY)Comparing NantHealth (NH) and Healthequity (HQY)
www.americanbankingnews.com - December 8 at 9:24 AM
Ronald Allen Louks Sells 5,245 Shares of NantHealth Inc (NH) StockRonald Allen Louks Sells 5,245 Shares of NantHealth Inc (NH) Stock
www.americanbankingnews.com - December 7 at 9:32 PM
Analyzing NantHealth (NH) & The CompetitionAnalyzing NantHealth (NH) & The Competition
www.americanbankingnews.com - December 6 at 11:20 AM
NantHealth to Support the University of California San Francisco in Research Initiative Focused on Metastatic Breast ... - Business Wire (press release)NantHealth to Support the University of California San Francisco in Research Initiative Focused on Metastatic Breast ... - Business Wire (press release)
www.businesswire.com - December 6 at 8:39 AM
Reviewing NantHealth (NH) and Greenway Health (GWAY)Reviewing NantHealth (NH) and Greenway Health (GWAY)
www.americanbankingnews.com - December 4 at 11:52 AM
NantHealth to Support the University of California San Francisco in Research Initiative Focused on Metastatic Breast CancerNantHealth to Support the University of California San Francisco in Research Initiative Focused on Metastatic Breast Cancer
finance.yahoo.com - December 4 at 8:29 AM
NantHealth (NH) versus Its Peers Head-To-Head AnalysisNantHealth (NH) versus Its Peers Head-To-Head Analysis
www.americanbankingnews.com - December 3 at 5:38 AM
Comparing NantHealth (NH) & Its PeersComparing NantHealth (NH) & Its Peers
www.americanbankingnews.com - December 3 at 1:24 AM
NantHealth (NH) & athenahealth (ATHN) Financial ReviewNantHealth (NH) & athenahealth (ATHN) Financial Review
www.americanbankingnews.com - November 24 at 3:28 AM
NantHealth, Inc. (NH) Stock Rating Upgraded by Zacks Investment ResearchNantHealth, Inc. (NH) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - November 23 at 9:16 PM
Head-To-Head Contrast: NantHealth (NH) and Its PeersHead-To-Head Contrast: NantHealth (NH) and Its Peers
www.americanbankingnews.com - November 23 at 9:14 PM
Castlight Health, inc. (CSLT) & NantHealth (NH) Financial SurveyCastlight Health, inc. (CSLT) & NantHealth (NH) Financial Survey
www.americanbankingnews.com - November 23 at 5:18 PM
NantHealth, Inc. (NH) Receives Consensus Recommendation of "Buy" from AnalystsNantHealth, Inc. (NH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 22 at 1:34 AM
NantHealth (NH) versus Its Peers Head to Head AnalysisNantHealth (NH) versus Its Peers Head to Head Analysis
www.americanbankingnews.com - November 19 at 5:06 PM

SEC Filings

NantHealth (NASDAQ:NH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

NantHealth (NASDAQ:NH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

NantHealth (NASDAQ NH) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.